Healthcare provider profile · identity verified

Guna Subedi, M.D.

Internal Medicine · FRONT ROYAL, VA · NPI 1598757221

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	478	130
Amlodipine Besylate	Amlodipine Besylate	448	124
Rosuvastatin Calcium	Rosuvastatin Calcium	389	117
Levothyroxine Sodium	Levothyroxine Sodium	324	79
Losartan Potassium	Losartan Potassium	303	83
Lisinopril	Lisinopril	279	76
Atenolol	Atenolol	225	57
Omeprazole	Omeprazole	206	66
Hydrochlorothiazide	Hydrochlorothiazide	200	53
Metoprolol Succinate	Metoprolol Succinate	200	61
Tamsulosin Hcl	Tamsulosin Hcl	184	50
Furosemide	Furosemide	179	61
Simvastatin	Simvastatin	174	50
Montelukast Sodium	Montelukast Sodium	164	44
Metformin Hcl Er	Metformin Hcl	163	43
Albuterol Sulfate Hfa	Albuterol Sulfate	139	43
Pantoprazole Sodium	Pantoprazole Sodium	130	41
Sertraline Hcl	Sertraline Hcl	130	34
Metformin Hcl	Metformin Hcl	123	35
Eliquis	Apixaban	119	33
Pravastatin Sodium	Pravastatin Sodium	116	36
Glimepiride	Glimepiride	113	32
Allopurinol	Allopurinol	107	33
Metoprolol Tartrate	Metoprolol Tartrate	104	29
Gabapentin	Gabapentin	101	33
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	96	23
Alprazolam	Alprazolam	94	27
Duloxetine Hcl	Duloxetine Hcl	91	20
Potassium Chloride	Potassium Chloride	88	31
Clopidogrel	Clopidogrel Bisulfate	87	27
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	85	26
Trazodone Hcl	Trazodone Hcl	84	25
Citalopram Hbr	Citalopram Hydrobromide	73	21
Ezetimibe	Ezetimibe	71	22
Ozempic	Semaglutide	69	16
Finasteride	Finasteride	64	20
Fluoxetine Hcl	Fluoxetine Hcl	64	19
Famotidine	Famotidine	63	17
Esomeprazole Magnesium	Esomeprazole Magnesium	62	19
Quetiapine Fumarate	Quetiapine Fumarate	61	12
Trulicity	Dulaglutide	61	12
Spironolactone	Spironolactone	60	15
Carvedilol	Carvedilol	59	15
Klor-Con M20	Potassium Chloride	54	18
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	53	14
Fenofibrate	Fenofibrate	52	17
Glipizide Er	Glipizide	52	13
Prednisone	Prednisone	52	30
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	50	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	47	13
Jardiance	Empagliflozin	44	suppressed
Warfarin Sodium	Warfarin Sodium	44	15
Cephalexin	Cephalexin	43	26
Synthroid	Levothyroxine Sodium	41	12
Tramadol Hcl	Tramadol Hcl	41	suppressed
Fluticasone Propionate	Fluticasone Propionate	40	12
Glipizide	Glipizide	39	suppressed
Meloxicam	Meloxicam	38	14
Indapamide	Indapamide	37	13
Venlafaxine Hcl Er	Venlafaxine Hcl	37	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	36	12
Colchicine	Colchicine	35	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	34	13
Bupropion Xl	Bupropion Hcl	33	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	32	suppressed
Ondansetron Hcl	Ondansetron Hcl	31	suppressed
Clonazepam	Clonazepam	30	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	30	suppressed
Eszopiclone	Eszopiclone	29	suppressed
Mounjaro	Tirzepatide	29	suppressed
Donepezil Hcl	Donepezil Hcl	28	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	27	11
Jantoven	Warfarin Sodium	26	suppressed
Mirtazapine	Mirtazapine	26	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	26	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	26	11
Hydralazine Hcl	Hydralazine Hcl	25	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	25	suppressed
Temazepam	Temazepam	25	suppressed
Amiodarone Hcl	Amiodarone Hcl	24	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	24	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	24	18
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	24	suppressed
Buspirone Hcl	Buspirone Hcl	22	suppressed
Lorazepam	Lorazepam	22	suppressed
Meclizine Hcl	Meclizine Hcl	22	12
Azithromycin	Azithromycin	21	19
Doxycycline Hyclate	Doxycycline Hyclate	21	17
Pregabalin	Pregabalin	21	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	19	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	19	suppressed
Ondansetron Odt	Ondansetron	19	suppressed
Valsartan	Valsartan	19	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	19	suppressed
Amiloride Hcl	Amiloride Hcl	18	suppressed
Ibandronate Sodium	Ibandronate Sodium	18	suppressed
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Clonidine Hcl	Clonidine Hcl	17	suppressed
Lansoprazole	Lansoprazole	17	suppressed
Nystatin	Nystatin	17	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	17	suppressed
Ramipril	Ramipril	17	suppressed
Ropinirole Hcl	Ropinirole Hcl	17	suppressed
Xarelto	Rivaroxaban	17	suppressed
Bupropion Hcl Sr	Bupropion Hcl	16	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	16	suppressed
Nystatin-Triamcinolone	Nystatin/Triamcinolone Acet	16	suppressed
Ventolin Hfa	Albuterol Sulfate	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	15	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	14	suppressed
Lovastatin	Lovastatin	14	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	13	13
Celecoxib	Celecoxib	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	suppressed
Clonidine	Clonidine	13	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	13	suppressed
Diltiazem Hcl	Diltiazem Hcl	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Januvia	Sitagliptin Phosphate	13	suppressed
Klor-Con M10	Potassium Chloride	13	suppressed
Labetalol Hcl	Labetalol Hcl	13	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	13	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Clorazepate Dipotassium	Clorazepate Dipotassium	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Folic Acid	Folic Acid	12	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	12	suppressed
Nabumetone	Nabumetone	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Calcitriol	Calcitriol	11	suppressed
Cilostazol	Cilostazol	11	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	11	suppressed
Farxiga	Dapagliflozin Propanediol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error